Acute restraint stress prevents nicotine-induced mesolimbic dopaminergic activation via a corticosterone-mediated mechanism: A microdialysis study in the rat

Drug and Alcohol Dependence

Volumn 127, Issue 1-3, 2013, Pages 8-14

  Enrico, Paolo ^a   Sirca, Donatella ^a   Mereu, Maddalena ^b   Peana, Alessandra Tiziana ^a   Mercante, Beniamina ^a   Diana, Marco ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Corticosterone; Immobilization stress; Mesolimbic dopamine system; Microdialysis; Nicotine

Indexed keywords

CORTICOSTERONE; DOPAMINE; MIFEPRISTONE; NICOTINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DOPAMINE METABOLISM; ENZYME INHIBITION; HORMONE SYNTHESIS; IMMOBILIZATION STRESS; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MICRODIALYSIS; MOTIVATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT;

ANIMALS; CORTICOSTERONE; DOPAMINE; LIMBIC SYSTEM; MALE; MICRODIALYSIS; MIFEPRISTONE; NICOTINE; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

RATTUS;

EID: 84870938442     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.06.006     Document Type: Article

References (88)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 1989, 52:1655-1658.
2. Anda R.F., Croft J.B., Felitti V.J., Nordenberg D., Giles W.H., Williamson D.F., Giovino G.A. Adverse childhood experiences and smoking during adolescence and adulthood. JAMA 1999, 282:1652-1658.
3. Baker R.R., Massey E.D., Smith G. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 2004, 42:S53-S83.
4. Balfour D.J., Wright A.E., Benwell M.E., Birrell C.E. The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav. Brain Res. 2000, 113:73-83.
5. Barrot M., Marinelli M., Abrous D.N., Rouge-Pont F., Le Moal M., Piazza P.V. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur. J. Neurosci. 2000, 12:973-979.
6. Blum K., Braverman E.R., Wood R.C., Gill J., Li C., Chen T.J., Taub M., Montgomery A.R., Sheridan P.J., Cull J.G. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics 1996, 6:297-305.
7. Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen T.J., Cull J.G., Comings D.E. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J. R. Soc. Med. 1996, 89:396-400.
8. Bouzat C.B., Barrantes F.J. Effects of long-chain fatty acids on the channel activity of the nicotinic acetylcholine receptor. Receptors Channels 1993, 1:251-258.
9. Brown Z.J., Erb S. Footshock stress reinstates cocaine seeking in rats after extended post-stress delays. Psychopharmacology (Berl.) 2007, 195:61-70.
10. Buczek Y., Le A.D., Wang A., Stewart J., Shaham Y. Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology (Berl.) 1999, 144:183-188.
11. Caggiula A.R., Donny E.C., Epstein L.H., Sved A.F., Knopf S., Rose C., McAllister C.G., Antelman S.M., Perkins K.A. The role of corticosteroids in nicotine's physiological and behavioral effects. Psychoneuroendocrinology 1998, 23:143-159.
12. Caggiula A.R., Epstein L.H., Antelman S.M., Saylor S., Knopf S., Perkins K.A., Stiller R. Acute stress or corticosterone administration reduces responsiveness to nicotine: implications for a mechanism of conditioned tolerance. Psychopharmacology (Berl.) 1993, 111:499-507.
13. Calabresi P., Lacey M.G., North R.A. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br. J. Pharmacol. 1989, 98:135-140.
14. Calvo N., Martijena I.D., Molina V.A., Volosin M. Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress. Brain Res. 1998, 800:227-235.
15. Campioni M.R., Xu M., McGehee D.S. Stress-induced changes in nucleus accumbens glutamate synaptic plasticity. J. Neurophysiol. 2009, 101:3192-3198.
16. Cao J., Belluzzi J.D., Loughlin S.E., Keyler D.E., Pentel P.R., Leslie F.M. Acetaldehyde, a major constituent of tobacco smoke, enhances behavioral, endocrine, and neuronal responses to nicotine in adolescent and adult rats. Neuropsychopharmacology 2007, 32:2025-2035.
17. Chaudhri N., Caggiula A.R., Donny E.C., Palmatier M.I., Liu X., Sved A.F. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl.) 2006, 184:353-366.
18. Chiamulera C. Cue reactivity in nicotine and tobacco dependence: a "multiple-action" model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli. Brain Res. 2005, 48:74-97.
19. Clark R.D. Glucocorticoid receptor antagonists. Curr. Top. Med. Chem. 2008, 8:813-838.
20. Cleck J.N., Blendy J.A. Making a bad thing worse: adverse effects of stress on drug addiction. J. Clin. Invest. 2008, 118:454-461.
21. Colby H.D. Chemical suppression of steroidogenesis. Environ. Health Perspect. 1981, 38:119-127.
22. Damsma G., Day J., Fibiger H.C. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 1989, 168:363-368.
23. de Kloet E.R. Stress in the brain. Eur. J. Pharmacol. 2000, 405:187-198.
24. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19:269-301.
25. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 1988, 85:5274-5278.
26. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 2000, 393:295-314.
27. Di Chiara G., Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr. Opin. Pharmacol. 2007, 7:69-76.
28. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004, 47:227-241.
29. Di Chiara G., Tanda G., Carboni E. Estimation of in vivo neurotransmitter release by brain microdialysis: the issue of validity. Behav. Pharmacol. 1996, 7:640-657.
30. Droste S.K., de Groote L., Atkinson H.C., Lightman S.L., Reul J.M., Linthorst A.C. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology 2008, 149:3244-3253.
31. Enrico P., Bouma M., de Vries J.B., Westerink B.H. The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain. Brain Res. 1998, 779:205-213.
32. Fa M., Carcangiu G., Passino N., Ghiglieri V., Gessa G.L., Mereu G. Cigarette smoke inhalation stimulates dopaminergic neurons in rats. Neuroreport 2000, 11:3637-3639.
33. Fagen Z.M., Mitchum R., Vezina P., McGehee D.S. Enhanced nicotinic receptor function and drug abuse vulnerability. J. Neurosci. 2007, 27:8771-8778.
34. Fuxe K., Agnati L.F., Jansson A., von Euler G., Tanganelli S., Andersson K., Eneroth P. Regulation of endocrine function by the nicotinic cholinergic receptor. Ciba Found. Symp. 1990, 152:113-127. discussion127-130.
35. Grun E.U., Pauly J.R., Bullock A.E., Collins A.C. Corticosterone reversibly alters brain alpha-bungarotoxin binding and nicotine sensitivity. Pharmacol. Biochem. Behav. 1995, 52:629-635.
36. Imperato A., Angelucci L., Casolini P., Zocchi A., Puglisi-Allegra S. Repeated stressful experiences differently affect limbic dopamine release during and following stress. Brain Res. 1992, 577:194-199.
37. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 1986, 132:337-338.
38. Imperato A., Puglisi-Allegra S., Casolini P., Angelucci L. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 1991, 538:111-117.
39. Joels M., Krugers H.J., Lucassen P.J., Karst H. Corticosteroid effects on cellular physiology of limbic cells. Brain Res. 2009, 1293:91-100.
40. Joels M., Pu Z., Wiegert O., Oitzl M.S., Krugers H.J. Learning under stress: how does it work?. Trends Cogn. Sci. 2006, 10:152-158.
41. Kalivas P.W., Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res. 1995, 675:325-328.
42. Kassel J.D., Stroud L.R., Paronis C.A. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol. Bull. 2003, 129:270-304.
43. Ke L., Lukas R.J. Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes. J. Neurochem. 1996, 67:1100-1112.
44. Klink R., de Kerchove d'Exaerde A., Zoli M., Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 2001, 21:1452-1463.
45. Koob G., Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatry 2007, 164:1149-1159.
46. Krugers H.J., Hoogenraad C.C., Groc L. Stress hormones and AMPA receptor trafficking in synaptic plasticity and memory. Nat. Rev. 2010, 11:675-681.
47. Le A.D., Quan B., Juzytch W., Fletcher P.J., Joharchi N., Shaham Y. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology (Berl.) 1998, 135:169-174.
48. Mansvelder H.D., McGehee D.S. Cellular and synaptic mechanisms of nicotine addiction. J. Neurobiol. 2002, 53:606-617.
49. Marinelli M. Dopaminergic reward pathways and effects of stress. Stress and Addiction - Biological and Psychological Mechanism 2007, 41-83. Elsevier, Amsterdam. P.D. Mustafa al'Absi (Ed.).
50. Markou A. Review. Neurobiology of nicotine dependence. Philos. Trans. R. Soc. London 2008, 363:3159-3168.
51. Marshall D.L., Redfern P.H., Wonnacott S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J. Neurochem. 1997, 68:1511-1519.
52. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., Craig C.R., Collins A.C., Damaj M.I., Donny E.C., Gardiner P.S., Grady S.R., Heberlein U., Leonard S.S., Levin E.D., Lukas R.J., Markou A., Marks M.J., McCallum S.E., Parameswaran N., Perkins K.A., Picciotto M.R., Quik M., Rose J.E., Rothenfluh A., Schafer W.R., Stolerman I.P., Tyndale R.F., Wehner J.M., Zirger J.M. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl.) 2007, 190:269-319.
53. McEwen B.S., De Kloet E.R., Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 1986, 66:1121-1188.
54. Melis M., Spiga S., Diana M. The dopamine hypothesis of drug addiction: hypodopaminergic state. Int. Rev. Neurobiol. 2005, 63:101-154.
55. Mereu G., Yoon K.W., Boi V., Gessa G.L., Naes L., Westfall T.C. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur. J. Pharmacol. 1987, 141:395-399.
56. Morissette S.B., Tull M.T., Gulliver S.B., Kamholz B.W., Zimering R.T. Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychol. Bull. 2007, 133:245-272.
57. Morsink M.C., Steenbergen P.J., Vos J.B., Karst H., Joëls M., De Kloet E.R., Datson N.A. Acute activation of hippocampal glucocorticoid receptors results in different waves of gene expression throughout time. J. Neuroendocrinol. 2006, 18:239-252.
58. Musazzi L., Milanese M., Farisello P., Zappettini S., Tardito D., Barbiero V.S., Bonifacino T., Mallei A., Baldelli P., Racagni G., Raiteri M., Benfenati F., Bonanno G., Popoli M. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PloS One 2010, 5:e8566.
59. National Research Council Guide for the Care and Use of Laboratory Animals 1996, National Academies Press, Washington, D.C.
60. Niehaus J.L., Murali M., Kauer J.A. Drugs of abuse and stress impair LTP at inhibitory synapses in the ventral tegmental area. Eur. J. Neurosci. 2010, 32:108-117.
61. Nisell M., Nomikos G.G., Svensson T.H. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol. Toxicol. 1994, 75:348-352.
62. Noguchi T., Yoshida Y., Chiba S. Effects of psychological stress on monoamine systems in subregions of the frontal cortex and nucleus accumbens of the rat. Brain Res. 2001, 916:91-100.
63. Pacchioni A.M., Gioino G., Assis A., Cancela L.M. A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors. Ann. N.Y. Acad. Sci. 2002, 965:233-246.
64. Pauly J.R., Grun E.U., Collins A.C. Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice. Psychopharmacology (Berl.) 1990, 101:310-316.
65. Pauly J.R., Ullman E.A., Collins A.C. Adrenocortical hormone regulation of nicotine sensitivity in mice. Physiol. Behav. 1988, 44:109-116.
66. Pauly J.R., Ullman E.A., Collins A.C. Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse. Pharmacol. Biochem. Behav. 1990, 35:171-179.
67. Pauly J.R., Collins A.C. An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation. Neuroendocrinology 1993, 57:262-271.
68. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2006, Elsevier, Amsterdam.
69. Pezze M.A., Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog. Neurobiol. 2004, 74:301-320.
70. Piazza P.V., Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 1998, 19:67-74.
71. Picciotto M.R., Brunzell D.H., Caldarone B.J. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 2002, 13:1097-1106.
72. Robinson S.F., Grun E.U., Pauly J.R., Collins A.C. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice. Pharmacol. Biochem. Behav. 1996, 54:587-593.
73. Saal D., Dong Y., Bonci A., Malenka R.C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003, 37:577-582.
74. Satoh E., Shimeki S. Acute restraint stress enhances calcium mobilization and glutamate exocytosis in cerebrocortical synaptosomes from mice. Neurochem. Res. 2010, 35:693-701.
75. Schilström B., Svensson H.M., Svensson T.H., Nomikos G.G. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroscience 1998, 85:1005-1009.
76. Schultz W. Behavioral dopamine signals. Trends Neurosci. 2007, 30:203-210.
77. Shors T.J., Weiss C., Thompson R.F. Stress-induced facilitation of classical conditioning. Science 1992, 257:537-539.
78. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl.) 2001, 158:343-359.
79. Söderpalm A., Nikolayev L., de Wit H. Effects of stress on responses to methamphetamine in humans. Psychopharmacology (Berl) 2003, 170:188-199.
80. Takahashi H., Takada Y., Nagai N., Urano T., Takada A. Previous exposure to footshock stress attenuates nicotine-induced serotonin release in rat striatum during the subsequent stress. Brain Res. Bull. 2000, 52:285-290.
81. Sonino N., Chow D., Levine L.S., New M.I. Clinical response to metyrapone as indicated by measurement of mineralocorticoids and glucocorticoids in normal children. Clin. Endocrinol. 1981, 14:31-39.
82. Spinella M. Compulsive behavior in tobacco users. Addict. Behav. 2005, 30:183-186.
83. Todd M. Daily processes in stress and smoking: effects of negative events, nicotine dependence, and gender. Psychol. Addict. Behav. 2004, 18:31-39.
84. Uhart M., Wand G.S. Stress, alcohol and drug interaction: an update of human research. Addict. Biol. 2009, 14:43-64.
85. Ungless M.A., Argilli E., Bonci A. Effects of stress and aversion on dopamine neurons: implications for addiction. Neurosci. Biobehav. Rev. 2010, 35:151-156.
86. Wang D.V., Tsien J.Z. Convergent processing of both positive and negative motivational signals by the VTA dopamine neuronal populations. PloS One 2011, 6:e17047.
87. Wise R.A. Dopamine, learning and motivation. Nat. Rev. 2004, 5:483-494.
88. Yuen E.Y., Liu W., Karatsoreos I.N., Feng J., McEwen B.S., Yan Z. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14075-14079.